24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Chiasma
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
10:27
University of Haifa in financial crisis: 170 lecturers fired or had positions reduced
09:41
From challenge to growth engine: Israel’s Haredi opportunity
21:15
China’s humanoid robots can outrun Usain Bolt. Now comes the hard part
21:09
Sam Altman admits he underestimated how slowly the economy would embrace AI
More stories
Buzz
Most popular
Daily
Weekly
1
After raising $51 million, Minimus shuts down as Twistlock founders return remaining cash to investors
2
Estonia weighs David’s Sling in billion-euro missile defense decision
3
Decart’s $7 billion Anthropic deal could become far more valuable after the IPO
4
SanDisk cuts dozens of jobs in Israel despite AI-fueled surge
5
The 50 most promising Israeli startups - 2026
More news
Chiasma
1 stories about Chiasma
Nasdaq-Listed Biopharma Company Chiasma Raises $34.5 Million in Public Offering
09.04.19
|
CTech
Chiasma develops octreotide capsules for the treatment of acromegaly, a rare, chronic disease typically caused by a benign tumor of the pituitary gland